M. O. Demirkol Et Al. , "The Utility of 68Ga-PSMA PET/CT in Poorly Differentiated Metastatic Prostate Cancer.," Clinical nuclear medicine , vol.42, no.5, pp.403-405, 2017
Demirkol, M. O. Et Al. 2017. The Utility of 68Ga-PSMA PET/CT in Poorly Differentiated Metastatic Prostate Cancer.. Clinical nuclear medicine , vol.42, no.5 , 403-405.
Demirkol, M. O., Kiremit, M. C., Acar, O., Ucar, B., & Saglican, Y., (2017). The Utility of 68Ga-PSMA PET/CT in Poorly Differentiated Metastatic Prostate Cancer.. Clinical nuclear medicine , vol.42, no.5, 403-405.
Demirkol, Mehmet Et Al. "The Utility of 68Ga-PSMA PET/CT in Poorly Differentiated Metastatic Prostate Cancer.," Clinical nuclear medicine , vol.42, no.5, 403-405, 2017
Demirkol, Mehmet O. Et Al. "The Utility of 68Ga-PSMA PET/CT in Poorly Differentiated Metastatic Prostate Cancer.." Clinical nuclear medicine , vol.42, no.5, pp.403-405, 2017
Demirkol, M. O. Et Al. (2017) . "The Utility of 68Ga-PSMA PET/CT in Poorly Differentiated Metastatic Prostate Cancer.." Clinical nuclear medicine , vol.42, no.5, pp.403-405.
@article{article, author={Mehmet Onur Demirkol Et Al. }, title={The Utility of 68Ga-PSMA PET/CT in Poorly Differentiated Metastatic Prostate Cancer.}, journal={Clinical nuclear medicine}, year=2017, pages={403-405} }